• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 9, 2015

View Archived Issues

Foamix reports topline results from phase II study of FDX-104

Read More

bluebird bio and ViroMed collaborate to develop CAR T-cell therapies

Read More

Athlete receives Zilosul for bone marrow edema under TGA Special Access Scheme

Read More

Merck & Co. reveals strategy to develop biosimilars in Canadian market

Read More

New trial evaluates use of stem cells to treat Alzheimer's disease

Read More

Cynata and Regience sign letter of intent for Cymerus alliance in Japan

Read More

Amgen and Merck & Co. form cancer immunotherapy collaboration

Read More

Samumed reports preliminary efficacy data from phase II study of SM-04554 for androgenetic alopecia

Read More

Tagging AR for degradation shows promise for prostate cancer

Read More

ADC Therapeutics cleared to start phase I trial of ADCT-402

Read More

Preclinical results for anticancer ADC and antibodies

Read More

Evofosfamide fails to increase overall survival in phase III trials

Read More

Johnson & Johnson acquires Novira Therapeutics

Read More

Midatech Pharma acquires DARA BioSciences

Read More

Novel neprilysin inhibitors exhibit good renal profile

Read More

Abcodia's ROCA test available in select U.S. states

Read More

University of Pennsylvania patents rAAV expressing dual antibody constructs

Read More

Roche discloses HER3/HER2 bispecific antibodies

Read More

Immunotope presents DENV universal vaccine candidates

Read More

Theravance initiates first-in-human study of NEP inhibitor TD-0714

Read More

EMA accepts MAA for Sandoz's etanercept biosimilar

Read More

Baxalta's Vonvendi is first FDA-approved recombinant von Willebrand factor

Read More

First clinical results show feasibility of first-in-class HGF/VEGF inhibitor MP-0250 in oncology

Read More

FDA approves Kanuma as first therapy for patients with lysosomal acid lipase deficiency

Read More

IL-15N72D/IL-15Ralpha-Fc superagonist complex shows promise for high-risk hematologic malignancies

Read More

Luspatercept receives FDA fast track designation for anemia in lower-risk MDS

Read More

FDA grants breakthrough therapy designation to Kite's KTE-C19

Read More

Sunesis files MAA for vosaroxin for AML in older adults

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe